A Retrospective Perspective: Evaluating Pulmonary Embolism Risk Factors and Survival Trends

CONTEXT: Pulmonary embolism (PE) is a serious condition that can lead to high rates of illness and death, often affected by different demographic, clinical, and treatment factors. Knowing how these factors work together is important for improving patient care and creating better management plans. AIMS: The goal of this study is to perform a detailed review of patients with a diagnosis of PE, looking into how factors such as age, gender, preexisting health issues, and medical treatments affect survival and disease development. SETTINGS AND DESIGN: This study was carried out in a hospital that provides advanced care, using patient records from individuals diagnosed with PE during a specific timeframe. The study design aimed to find links between demographic, clinical, and treatment factors and their effects on patient outcomes. Data were collected and analyzed systematically to assess trends in survival rates and disease progression in relation to important predictors. SUBJECTS AND METHODS: Data were gathered from patient records of those diagnosed with PE. Demographic and clinical information was examined to uncover trends linked to higher risks and survival rates. STATISTICAL ANALYSIS USED: The analysis was performed using SPSS/PC software, and Chi-square tests were used to examine differences in demographic features and comorbidities, with a significance level set at P < 0.05. RESULTS: The results indicate that age, sex, and the existence of comorbidities have a significant effect on survival rates in patients with PE. Higher mortality was observed in patients over 65, as well as in those with additional cardiovascular and respiratory conditions. Certain treatments were also associated with improved survival rates, highlighting the importance of timely and tailored clinical intervention. CONCLUSIONS: This retrospective study underscores the critical role of demographic and clinical factors in shaping PE outcomes. Age and comorbidities are significant risk factors for mortality in PE patients, while specific treatment approaches correlate with improved survival. These findings support the need for personalized treatment strategies and targeted interventions to enhance patient survival in PE.